(1)DaimlerChrysler signs contract to make Mercedes cars in China

(1)DaimlerChrysler signs contract to make Mercedes cars in China

BEIJING, China - Representatives of German automaker DaimlerChrysler AG and Beijing Automotive Industry Holding Co. sign an agreement in Beijing on Sept. 8 to make 25,000 Mercedes-Benz cars within the next few years in the Chinese capital. (Kyodo)

  • Product Code
  • ILEA000021189
  • Registered date
  • 2003/9/08 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 1710 × 1221 pixel
  • Resolution
  • 72 dpi
  • Deployment size
  • 469.14(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

    Tokyo bourse extends closing time

    TOKYO, Japan, Nov. 5 Kyodo - Video taken on Nov. 5, 2024, captures a financial data screen at the Tokyo Stock Exchange showing trading continuing past 3 p.m. after the bourse extended its closing time by 30 minutes to 3:30 p.m., the first extension in 70 years. (Kyodo)
      Traffic in Beijing

      Traffic in Beijing

      Masses of vehicles move slowly on a road in smog during morning rush hours in Beijing, China, on October 29, 2024. LEHTIKUVA / MARKKU ULANDER - FINLAND OUT. NO THIRD PARTY SALES. (Credit:Markku Ulander/Lehtikuva/Kyodo News Images)
        Traffic in Beijing

        Traffic in Beijing

        Masses of vehicles move slowly on a road in smog during morning rush hours in Beijing, China, on October 29, 2024. LEHTIKUVA / MARKKU ULANDER - FINLAND OUT. NO THIRD PARTY SALES. (Credit:Markku Ulander/Lehtikuva/Kyodo News Images)
          Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

          Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

          BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
            Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

            Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

            BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
              Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

              Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

              BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
                Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                Sanofi 15 Billion Sale Of Opella And Doliprane To CDR

                BAYEUX, FRANCE - OCTOBER 13: A view of Doliprane 1000g boxes placed in front of a computer screen displaying the Sanofi logo, in Bayeux, Calvados, France, on October 13, 2024. Sanofi, the world's fifth-largest pharmaceutical company, is divesting a portion of its business by selling its consumer healthcare division, Opella, which includes around a hundred of its consumer health products, to the American investment fund Clayton, Dubilier and Rice (CDandR) for over 15 billion euros. (Photo by Artur Widak/NurPhoto)
                  U.S. Port Strike Ends

                  U.S. Port Strike Ends

                  A general view of containers and cranes in Lisbon, Portugal, on October 4, 2024. The union representing 45,000 striking U.S. dockworkers at East and Gulf coast ports reaches a deal to suspend a three-day strike until January 15 to provide time to negotiate a new contract. The tentative deal includes a 62% wage hike over six years. (Photo by Luis Boza/NurPhoto via Getty Images) (Photo by Luis Boza/NurPhoto)
                    U.S. Port Strike Ends

                    U.S. Port Strike Ends

                    A general view of the cargo port in Lisbon, Portugal, on October 4, 2024. The union representing 45,000 striking U.S. dockworkers at East and Gulf coast ports reaches a deal to suspend a three-day strike until January 15 to provide time to negotiate a new contract. The tentative deal includes a 62% wage hike over six years. (Photo by Luis Boza/NurPhoto via Getty Images) (Photo by Luis Boza/NurPhoto)
                      U.S. Port Strike Ends

                      U.S. Port Strike Ends

                      A sailboat is seen near the cargo port in Lisbon, Portugal, on October 4, 2024. The union representing 45,000 striking U.S. dockworkers at East and Gulf coast ports reaches a deal to suspend a three-day strike until January 15 to provide time to negotiate a new contract. The tentative deal includes a 62% wage hike over six years. (Photo by Luis Boza/NurPhoto via Getty Images) (Photo by Luis Boza/NurPhoto)